Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm, BD Biosciences to Co-host Seminars on Combined Technologies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm and BD Biosciences today announced they will co-host a series of public seminars on the isolation and analysis of single cells using a combination of their technologies.

The seminars will discuss the experimental workflows of the companies' technologies and showcase cell isolation using the BD FacsAria III Cell Sorter and analysis on the Fluidigm BioMark HD System.

In a statement, Fluidigm said that "the combination of both the cell surface phenotype obtained from cell sorting and the gene expression profiles of individual cells isolated from a heterogeneous population of cells provides a deeper view into cellular systems."

Gajus Worthington, president and CEO of Fluidigm, added, "We believe this emerging field of single-cell genomics research will help elucidate the underlying biomolecular processes across many diverse biomedical research areas."

BD cell sorting systems allows researchers to isolate single cells from thousands of cells using up to 18 surface markers, Fluidigm said. Using the Fluidigm platform to assay for differential expression levels allows for the assessment of cellular heterogeneity and the cellular biomolecular processes.

"We believe that joining our expertise in cell sorting with Fluidigm's ability to provide real-time polymerase chain reaction gene expression profiles of hundreds of genes from multiple minute samples will greatly simplify and advance single-cell research," said James Glasscock, president of BD Biosciences, a segment of Becton Dickinson.

Seminars are planned for the San Francisco Bay Area, New York, Boston, Houston, and Montreal. Locations also include a number of private institutions in North America.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.